A longtime goal for cardiac surgeons now appears to be within reach, according to researchers out of Massachusetts General Hospital.

The findings were presented Friday, Oct. 16, at TCT Connect 2020.

The analysis included data from nearly 800 patients with a history of chronic heart failure. 

The researchers think their findings may explain why so many cancer survivors go on to experience heart failure.

However, these trends do not appear to be true for all heart failure patients. 

In-hospital mortality, myocardial injury and acute kidney injury were all more common when patients with a history of heart failure tested positive for COVID-19. 

Clinicians should consider the potential negative impact of prescribing so many medications at once, the study's authors noted. 

The study's authors explored data from six different randomized, placebo-controlled trials.

The map, part of a study published in Nature, can provide new details about cellular structure and how cells interact with one another. It could even help with the treatment of COVID-19.